Tranexamic Acid PCD Pharma Franchise Company

Cafoli Lifecare is a WHO-GMP certified PCD pharma franchise company offering a Tranexamic Acid range of 20 formulations across tablet, injection and cream forms — one of the largest single-molecule ranges in our portfolio. All products are manufactured at approved facilities and offered with district-level monopoly rights.

What is Tranexamic Acid?

Tranexamic acid is an antifibrinolytic agent — a synthetic analogue of the amino acid lysine. It occupies the lysine-binding sites on plasminogen, which prevents plasminogen from attaching to fibrin and being converted into plasmin. Without plasmin, the fibrin clot is not broken down, so bleeding is controlled. It is used to reduce or prevent bleeding in heavy menstrual periods, surgery, trauma and dental procedures, and is on the WHO Model List of Essential Medicines. Topically, it is used in dermatology for melasma. It is prescription-only. Compound and pharmacology data are available on PubChem.

Tranexamic Acid Formulations Available with Cafoli Lifecare

The range comprises 20 formulations across tablet, injection and cream presentations, including combination products used in gynaecology and dermatology. Composition, packing and net rates are shared on enquiry.

Therapeutic Applications of Tranexamic Acid

• Heavy menstrual bleeding (menorrhagia) and dysfunctional uterine bleeding
• Prevention and control of surgical and post-operative haemorrhage
• Trauma-associated haemorrhage, given early (injection)
• Post-partum haemorrhage, as part of obstetric protocols
• Dental extraction in patients with bleeding disorders; epistaxis
• Melasma and post-inflammatory hyperpigmentation (topical cream)

Prescribers therefore include gynaecologists and obstetricians, surgeons and anaesthetists, emergency and trauma physicians, dentists, ENT surgeons and dermatologists.

Why Tranexamic Acid is a High-Potential Molecule for Distributors

Few molecules let a distributor knock on this many doors with the same product code. Tranexamic acid works as a life-saving injectable in trauma bays and operation theatres, as a routine oral tablet in every gynaecology OPD in the country, and — increasingly — as a topical cream in cosmetic dermatology. Those are three completely different call cycles feeding one stock list, and the 20-SKU range means you can service all three without gaps. The gynaecology base alone is enormous and recurring: heavy menstrual bleeding is treated cycle after cycle, not once. The dermatology cream, meanwhile, is riding the fastest-growing segment in Indian derma, where melasma treatment is a high-repeat, cash-paying category. And because tranexamic acid sits on the WHO Essential Medicines list and in obstetric haemorrhage protocols, its institutional demand is protocol-driven rather than promotion-dependent.

Why Choose Cafoli Lifecare for Your Tranexamic Acid Franchise

• Monopoly rights — one partner per district, territory protected
• WHO-GMP certified manufacturing and DCGI-approved formulations
• Promotional inputs — visual aids, doctor sample packs, literature, reminder gifts and MR bags
• 1000+ franchise partners across India
• On-time despatch, transparent net rates and dedicated order support

References

1. PubChem — Tranexamic acid compound record, National Library of Medicine
2. WHO Model List of Essential Medicines
3. PubMed — clinical literature on tranexamic acid